These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
331 related articles for article (PubMed ID: 14724567)
1. Ribozyme-mediated inhibition of survivin expression increases spontaneous and drug-induced apoptosis and decreases the tumorigenic potential of human prostate cancer cells. Pennati M; Binda M; Colella G; Zoppe' M; Folini M; Vignati S; Valentini A; Citti L; De Cesare M; Pratesi G; Giacca M; Daidone MG; Zaffaroni N Oncogene; 2004 Jan; 23(2):386-94. PubMed ID: 14724567 [TBL] [Abstract][Full Text] [Related]
2. Adenovirus-mediated inhibition of survivin expression sensitizes human prostate cancer cells to paclitaxel in vitro and in vivo. Zhang M; Mukherjee N; Bermudez RS; Latham DE; Delaney MA; Zietman AL; Shipley WU; Chakravarti A Prostate; 2005 Aug; 64(3):293-302. PubMed ID: 15754318 [TBL] [Abstract][Full Text] [Related]
3. Survivin mediates resistance to antiandrogen therapy in prostate cancer. Zhang M; Latham DE; Delaney MA; Chakravarti A Oncogene; 2005 Apr; 24(15):2474-82. PubMed ID: 15735703 [TBL] [Abstract][Full Text] [Related]
4. Ribozyme-mediated down-regulation of survivin expression sensitizes human melanoma cells to topotecan in vitro and in vivo. Pennati M; Binda M; De Cesare M; Pratesi G; Folini M; Citti L; Daidone MG; Zunino F; Zaffaroni N Carcinogenesis; 2004 Jul; 25(7):1129-36. PubMed ID: 14764461 [TBL] [Abstract][Full Text] [Related]
5. Ribozyme-mediated inhibition of PKCalpha sensitizes androgen-independent human prostate cancer cells to cisplatin-induced apoptosis. Orlandi L; Binda M; Folini M; Bearzatto A; Villa R; Daidone MG; Zaffaroni N Prostate; 2003 Feb; 54(2):133-43. PubMed ID: 12497586 [TBL] [Abstract][Full Text] [Related]
6. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo. Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823 [TBL] [Abstract][Full Text] [Related]
7. Ribozyme-mediated cleavage of the human survivin mRNA and inhibition of antiapoptotic function of survivin in MCF-7 cells. Choi KS; Lee TH; Jung MH Cancer Gene Ther; 2003 Feb; 10(2):87-95. PubMed ID: 12536196 [TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells. Rahman KW; Li Y; Wang Z; Sarkar SH; Sarkar FH Cancer Res; 2006 May; 66(9):4952-60. PubMed ID: 16651453 [TBL] [Abstract][Full Text] [Related]
9. Aspirin enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in hormone-refractory prostate cancer cells through survivin down-regulation. Yoo J; Lee YJ Mol Pharmacol; 2007 Dec; 72(6):1586-92. PubMed ID: 17848598 [TBL] [Abstract][Full Text] [Related]
10. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo. Li B; Liu X; Fan J; Qi R; Bo L; Gu J; Qian Q; Qian C; Liu X J Gene Med; 2006 Oct; 8(10):1232-42. PubMed ID: 16900558 [TBL] [Abstract][Full Text] [Related]
11. Transcriptional targeting of tumors with a novel tumor-specific survivin promoter. Zhu ZB; Makhija SK; Lu B; Wang M; Kaliberova L; Liu B; Rivera AA; Nettelbeck DM; Mahasreshti PJ; Leath CA; Barker S; Yamaoto M; Li F; Alvarez RD; Curiel DT Cancer Gene Ther; 2004 Apr; 11(4):256-62. PubMed ID: 15017380 [TBL] [Abstract][Full Text] [Related]
12. Aspirin sensitizes cancer cells to TRAIL-induced apoptosis by reducing survivin levels. Lu M; Strohecker A; Chen F; Kwan T; Bosman J; Jordan VC; Cryns VL Clin Cancer Res; 2008 May; 14(10):3168-76. PubMed ID: 18483385 [TBL] [Abstract][Full Text] [Related]
13. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells. Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707 [TBL] [Abstract][Full Text] [Related]
14. Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells. Gritsko T; Williams A; Turkson J; Kaneko S; Bowman T; Huang M; Nam S; Eweis I; Diaz N; Sullivan D; Yoder S; Enkemann S; Eschrich S; Lee JH; Beam CA; Cheng J; Minton S; Muro-Cacho CA; Jove R Clin Cancer Res; 2006 Jan; 12(1):11-9. PubMed ID: 16397018 [TBL] [Abstract][Full Text] [Related]
15. GLI2 knockdown using an antisense oligonucleotide induces apoptosis and chemosensitizes cells to paclitaxel in androgen-independent prostate cancer. Narita S; So A; Ettinger S; Hayashi N; Muramaki M; Fazli L; Kim Y; Gleave ME Clin Cancer Res; 2008 Sep; 14(18):5769-77. PubMed ID: 18794086 [TBL] [Abstract][Full Text] [Related]
16. Procaspase 3 expression in ovarian carcinoma cells increases survivin transcription which can be countered with a dominant-negative mutant, survivin T34A; a combination gene therapy strategy. McKay TR; Bell S; Tenev T; Stoll V; Lopes R; Lemoine NR; McNeish IA Oncogene; 2003 Jun; 22(23):3539-47. PubMed ID: 12789262 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer. Ai Z; Yin L; Zhou X; Zhu Y; Zhu D; Yu Y; Feng Y Cancer; 2006 Aug; 107(4):746-56. PubMed ID: 16826583 [TBL] [Abstract][Full Text] [Related]
18. Radiosensitization of human melanoma cells by ribozyme-mediated inhibition of survivin expression. Pennati M; Binda M; Colella G; Folini M; Citti L; Villa R; Daidone MG; Zaffaroni N J Invest Dermatol; 2003 Apr; 120(4):648-54. PubMed ID: 12648230 [TBL] [Abstract][Full Text] [Related]
19. Induction of apoptosis in human ovarian epithelial cancer cells by antisurvivin oligonucleotides. Ma X; Wang S; Zhou J; Xing H; Xu G; Wang B; Chen G; Lu YP; Ma D Oncol Rep; 2005 Jul; 14(1):275-9. PubMed ID: 15944801 [TBL] [Abstract][Full Text] [Related]
20. Expression of the survivin gene in prostate cancer: correlation with clinicopathological characteristics, proliferative activity and apoptosis. Kishi H; Igawa M; Kikuno N; Yoshino T; Urakami S; Shiina H J Urol; 2004 May; 171(5):1855-60. PubMed ID: 15076293 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]